Literature DB >> 13750628

The clinical application of aldosterone antagonists in the treatment of oedema.

S SHALDON.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/antagonists; DIURETICS/therapy; EDEMA/therapy

Mesh:

Substances:

Year:  1961        PMID: 13750628      PMCID: PMC1870342     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  6 in total

1.  Clinical and metabolic effects of aldosterone antagonism.

Authors:  J D SLATER; A MOXHAM; R HURTER; J D NABARRO
Journal:  Lancet       Date:  1959-11-28       Impact factor: 79.321

2.  The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.

Authors:  D N KERR; A E READ; R M HASLAM; S SHERLOCK
Journal:  Lancet       Date:  1958-11-22       Impact factor: 79.321

3.  Aldosterone antagonists.

Authors:  G W LIDDLE
Journal:  AMA Arch Intern Med       Date:  1958-12

4.  Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).

Authors:  S SHALDON; J R McLAREN; S SHERLOCK
Journal:  Lancet       Date:  1960-03-19       Impact factor: 79.321

5.  Chlorothiazide in control of ascites in hepatic cirrhosis.

Authors:  A E READ; R M HASLAM; J LAIDLAW; S SHERLOCK
Journal:  Br Med J       Date:  1958-04-26

6.  The treatment and prognosis of hepatic coma.

Authors:  A M DAWSON; S SHERLOCK; W H SUMMERSKILL
Journal:  Lancet       Date:  1956-10-06       Impact factor: 79.321

  6 in total
  3 in total

1.  SPIRONOLACTONE AS AN ADJUVANT TO THE TREATMENT OF CONGESTIVE CARDIAC FAILURE.

Authors:  D W EVANS; C T FLEAR; J G DOMENET
Journal:  Postgrad Med J       Date:  1964-01       Impact factor: 2.401

2.  Diuretics.

Authors:  G M WILSON
Journal:  Br Med J       Date:  1963-02-02

3.  A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascites.

Authors:  S SHALDON; J A RYDER; M GARSENSTEIN
Journal:  Gut       Date:  1963-03       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.